Blood Cancer

Pharmaxis Ltd has multiple potential value inflection points with two drugs advancing in clinical trials [Video]

  • Pharmaxis attracts A$0.53 price target in coverage initiation from MST Access
  • Pharmaxis’ treatment to prevent wound and burns scars clears phase1 trial
  • Pharmaxis welcomes green light to progress to Phase 2 bone marrow cancer trial

Quick facts: Pharmaxis Ltd



Price: 0.11 AUD

Market Cap: $49.98 m

About the company

Pharmaxis Ltd is an Australian pharmaceutical research company developing drugs for inflammatory and fibrotic diseases, with a focus on myelofibrosis.

The company has a highly productive drug discovery engine, drug candidates in clinical trials and two respiratory products approved in global markets generating ongoing revenue.

Pharmaxis’ lead drug candidate (PXS-5505) is for the treatment of the bone marrow cancer myelofibrosis, which affects 1 in 500,000 people.

Another Pharmaxis drug discovery, PXS‐6302 has entered a world-first clinical trial aiming to stop scars that are formed after surgery or trauma, particularly following burn injuries.

Pharmaxis has developed two products from its proprietary spray drying technology that …

Watch/Read More
Blood Cancer

Jeff Bridges on surviving cancer and COVID [Video]

The Oscar-winning actor, who'd led a seemingly charmed life as the star of such hits as "Crazy Heart" and "The Big Lebowski," talks with Turner Classic Movies host Ben Mankiewicz about his terrifying health crises – from his lymphoma diagnosis, to spending five weeks in the hospital with COVID-19 contracted while undergoing chemo – and how he emerged with an even greater feeling of connection."CBS Sunday Morning" features stories on the arts, music, nature, entertainment, sports, history, science and Americana, and highlights unique human accomplishments and achievements. Check local listings for CBS Sunday Morning broadcast times.Subscribe to the "CBS Sunday Morning" YouTube channel: more of "CBS Sunday Morning": "CBS Sunday Morning" on Instagram: "CBS Sunday Morning" on Facebook: "CBS Sunday Morning" on Twitter: to our newsletter: the CBS News app: Paramount+ free: video licensing inquiries, contact: